Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing Radiotherapy

被引:0
|
作者
Thunshelle, C. P. [1 ]
Kouzy, R. [1 ]
Jaoude, J. Abi [1 ]
Chowdhury, T. [1 ]
Zaid, M. [1 ]
Mathew, R. [1 ]
Prakash, L. [2 ]
Katz, M. H. G. [2 ]
Minsky, B. D. [1 ]
Holliday, E., Jr. [1 ]
Das, P. [1 ]
Smith, G. L. [1 ]
Herman, J. M. [1 ]
Koong, A. C. [3 ]
Taniguchi, C. M. [1 ]
Wang, X. S. [4 ]
Koay, E. J. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3451
引用
收藏
页码:E628 / E628
页数:1
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Roberto Alva-Ruiz
    Lavanya Yohanathan
    Jennifer A. Yonkus
    Amro M. Abdelrahman
    Lindsey A. Gregory
    Thorvadur R. Halfdanarson
    Amit Mahipal
    Robert R. McWilliams
    Wen Wee Ma
    Christopher L. Hallemeier
    Rondell P. Graham
    Travis E. Grotz
    Rory L. Smoot
    Sean P. Cleary
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
  • [22] Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer
    Shaib, Walid L.
    Ip, Andrew
    Cardona, Kenneth
    Alese, Olatunji B.
    Maithel, Shishir K.
    Kooby, David
    Landry, Jerome
    El-Rayes, Bassel F.
    ONCOLOGIST, 2016, 21 (02): : 178 - 187
  • [23] A Prospective Cohort Analysis of Patient-Reported Outcomes in Patients at High Risk for Breast Cancer
    Yoshida, Cassidy
    Huey, Madeline
    Adams, Monica
    Vemuru, Sudheer
    Parris, Hannah J.
    Huynh, Victoria
    Goode, Jennifer
    Becker, Nicole
    Davis, Nicole
    Tevis, Sarah
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S47 - S48
  • [24] Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
    Maggino, Laura
    Malleo, Giuseppe
    Marchegiani, Giovanni
    Viviani, Elena
    Nessi, Chiara
    Ciprani, Debora
    Esposito, Alessandro
    Landoni, Luca
    Casetti, Luca
    Tuveri, Massimiliano
    Paiella, Salvatore
    Casciani, Fabio
    Sereni, Elisabetta
    Binco, Alessandra
    Bonamini, Deborah
    Secchettin, Erica
    Auriemma, Alessandra
    Merz, Valeria
    Simionato, Francesca
    Zecchetto, Camilla
    D'Onofrio, Mirko
    Melisi, Davide
    Bassi, Claudio
    Salvia, Roberto
    JAMA SURGERY, 2019, 154 (10) : 932 - 942
  • [25] Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancer
    Rompen, Ingmar F.
    Marchetti, Alessio
    Levine, Jonah
    Swett, Benjamin
    Galimberti, Veronica
    Han, Jane
    Riachi, Mansour E.
    Habib, Joseph R.
    Imam, Rami
    Kaplan, Brian
    Sacks, Greg D.
    Cao, Wenqing
    Wolfgang, Christopher L.
    Javed, Ammar A.
    Hewitt, D. Brock
    SURGERY, 2025, 180
  • [26] Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy
    Rosati, L. M.
    He, J.
    Moningi, S.
    Hacker-Prietz, A.
    Huebner, T. A.
    Assadi, R. K.
    Laheru, D. A.
    Zheng, L.
    De Jesus-Acosta, A.
    Le, D. T.
    Fishman, E. K.
    Hruban, R. H.
    Hirose, K.
    Makary, M. A.
    Cameron, J. L.
    Pawlik, T. M.
    Wolfgang, C. L.
    Weiss, M. J.
    Ellsworth, S. G.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E127 - E128
  • [27] Symptoms as Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies
    Mendoza, Tito R.
    IMMUNOTHERAPY, 2ND EDITION, 2018, 995 : 165 - 182
  • [28] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [29] Patient-reported and clinical outcomes among patients with pancreatic cancer
    Pichardo, Rayli
    Jacob, Brigid
    Jamil, Maria
    Jamil, Dawood
    Raslan, Shahm
    Rose, Courtney M.
    Boakye, Eric Adjei
    Poisson, Laila
    Tam, Samantha
    Philip, Philip A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer
    Del Chiaro, Marco
    Rangelova, Elena
    Halimi, Asif
    Ateeb, Zeeshan
    Scandavini, Chiara
    Valente, Roberto
    Segersvard, Ralf
    Arnelo, Urban
    Verbeke, Caroline S.
    HPB, 2019, 21 (02) : 219 - 225